Search research articles
Contact Us
Filters
Showing results (101-110 of 175) with videos related to
Page
of 18
Sort By:
Leukemia
|
December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
C S Chim, S K Kumar, R Z Orlowski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma
P Thilakarathne, A Palumbo, J Diels, et al.
Leukemia
|
March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
C S Chim, S K Kumar, R Z Orlowski, et al.
Haematologica
|
June 15, 1999
Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery
M C del Cañizo, N Lopez, L Vazquez, et al.
Hematology Reports
|
January 9, 2015
Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
Renata Cabral, Juan Carlos Caballero, Sara Alonso, et al.
Haematologica
|
August 6, 2002
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study
Rodrigo Martino, Granada Perea, María Dolores Caballero, et al.
Thrombosis Research
|
September 29, 2006
Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism
J R Gonzalez-Porras, F Martin-Herrero, R Garcia-Sanz, et al.
Acta Neurologica Scandinavica
|
December 13, 2006
Almotriptan and zolmitriptan in the acute treatment of migraine
P J Goadsby, H Massiou, J Pascual, et al.
Leukemia
|
July 30, 2002
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
J A Pérez-Simón, D Caballero, M Diez-Campelo, et al.
Bone Marrow Transplantation
|
March 14, 2003
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
D Valcárcel, R Martino, D Caballero, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 175) with videos related to
Sort By:
Page
of 18
Leukemia
|
December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
C S Chim, S K Kumar, R Z Orlowski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma
P Thilakarathne, A Palumbo, J Diels, et al.
Leukemia
|
March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
C S Chim, S K Kumar, R Z Orlowski, et al.
Haematologica
|
June 15, 1999
Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery
M C del Cañizo, N Lopez, L Vazquez, et al.
Hematology Reports
|
January 9, 2015
Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
Renata Cabral, Juan Carlos Caballero, Sara Alonso, et al.
Haematologica
|
August 6, 2002
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study
Rodrigo Martino, Granada Perea, María Dolores Caballero, et al.
Thrombosis Research
|
September 29, 2006
Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism
J R Gonzalez-Porras, F Martin-Herrero, R Garcia-Sanz, et al.
Acta Neurologica Scandinavica
|
December 13, 2006
Almotriptan and zolmitriptan in the acute treatment of migraine
P J Goadsby, H Massiou, J Pascual, et al.
Leukemia
|
July 30, 2002
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
J A Pérez-Simón, D Caballero, M Diez-Campelo, et al.
Bone Marrow Transplantation
|
March 14, 2003
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
D Valcárcel, R Martino, D Caballero, et al.
Page
of 18